Corvus Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - January 4, 2016

Attached files

file filename
S-1 - S-1 - Corvus Pharmaceuticals, Inc.a2226867zs-1.htm
EX-10.4(D) - EX-10.4(D) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4d.htm
EX-10.9(A) - EX-10.9(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_9a.htm
EX-10.13(A) - EX-10.13(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_13a.htm
EX-4.2 - EX-4.2 - Corvus Pharmaceuticals, Inc.a2226867zex-4_2.htm
EX-10.9(B) - EX-10.9(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_9b.htm
EX-10.2(A) - EX-10.2(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_2a.htm
EX-3.1 - EX-3.1 - Corvus Pharmaceuticals, Inc.a2226867zex-3_1.htm
EX-3.2 - EX-3.2 - Corvus Pharmaceuticals, Inc.a2226867zex-3_2.htm
EX-3.3 - EX-3.3 - Corvus Pharmaceuticals, Inc.a2226867zex-3_3.htm
EX-3.4 - EX-3.4 - Corvus Pharmaceuticals, Inc.a2226867zex-3_4.htm
EX-10.8 - EX-10.8 - Corvus Pharmaceuticals, Inc.a2226867zex-10_8.htm
EX-10.7 - EX-10.7 - Corvus Pharmaceuticals, Inc.a2226867zex-10_7.htm
EX-10.1 - EX-10.1 - Corvus Pharmaceuticals, Inc.a2226867zex-10_1.htm
EX-10.4(B) - EX-10.4(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4b.htm
EX-10.12 - EX-10.12 - Corvus Pharmaceuticals, Inc.a2226867zex-10_12.htm
EX-10.4(A) - EX-10.4(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4a.htm
EX-10.2(C) - EX-10.2(C) - Corvus Pharmaceuticals, Inc.a2226867zex-10_2c.htm
EX-10.4(F) - EX-10.4(F) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4f.htm
EX-10.5(C) - EX-10.5(C) - Corvus Pharmaceuticals, Inc.a2226867zex-10_5c.htm
EX-10.11 - EX-10.11 - Corvus Pharmaceuticals, Inc.a2226867zex-10_11.htm
EX-10.15 - EX-10.15 - Corvus Pharmaceuticals, Inc.a2226867zex-10_15.htm
EX-10.5(D) - EX-10.5(D) - Corvus Pharmaceuticals, Inc.a2226867zex-10_5d.htm
EX-10.2(B) - EX-10.2(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_2b.htm
EX-10.5(B) - EX-10.5(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_5b.htm
EX-10.14 - EX-10.14 - Corvus Pharmaceuticals, Inc.a2226867zex-10_14.htm
EX-10.13(B) - EX-10.13(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_13b.htm
EX-10.10(B) - EX-10.10(B) - Corvus Pharmaceuticals, Inc.a2226867zex-10_10b.htm
EX-10.10(A) - EX-10.10(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_10a.htm
EX-10.6 - EX-10.6 - Corvus Pharmaceuticals, Inc.a2226867zex-10_6.htm
EX-10.4(E) - EX-10.4(E) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4e.htm
EX-10.4(C) - EX-10.4(C) - Corvus Pharmaceuticals, Inc.a2226867zex-10_4c.htm
EX-10.5(A) - EX-10.5(A) - Corvus Pharmaceuticals, Inc.a2226867zex-10_5a.htm

QuickLinks -- Click here to rapidly navigate through this document


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        We hereby consent to the use in this Registration Statement on Form S-1 of Corvus Pharmaceuticals, Inc. of our report dated November 6, 2015 relating to the financial statements of Corvus Pharmaceuticals, Inc., which appears in such Registration Statement. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ PricewaterhouseCoopers LLP
San Jose, California
January 4, 2016



QuickLinks

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Corvus Pharmaceuticals, Inc. Reports